Uses of one or more among smilagenin, pleasedigenin, an astragaloside, tigogenin, ruscogenin, hecogenin, diogenin, smilagenin, anzurogenin d or an astragaloside and an extract from a plant of the genus smilax, asparagus, anemarrhena, yucca, yucca or yucca. for the treatment of a condition distinguished by a deficiency in the function or the number of membrane-bound postsynaptic receptors, pharmaceutical composition, and, processes to enhance cognitive function in a human or non-human animal and in a patient suffering from an age-related cognitive impairment, and to treat a condition distinguished by a deficiency in function or the number of membrane-bound receptors in a tissue, organ, cell type or organelle

摘要

"USES OF ONE OR MORE INSIDE SMILAGENIN, PRAZERIGENIN, AN ASTRAGALOSYDE, TIGOGENIN, RUSCOGENIN, HECOGENIN, DIOSGENINE, ESMYLAGENINE, ANZUROGENIN D OR AN ASTRAGALOSYDE AND AN EXTRACTION OF AN AGAIN, ANY AGAIN AGAIN COMPOSITION FOR THE TREATMENT OF A CONDITION DISTINGUISHED BY A DEFICIENCY OF THE FUNCTION OR THE NUMBER OF POST-SYNAPTIC RECEPTORS CONNECTED TO THE MEMBRANE, PHARMACEUTICAL COMPOSITION, AND PROCESSES TO ENHANCE THE COGNITIVE FUNCTION IN A HUMAN HUMAN HUMAN HUMAN OF A COGNITIVE DYSFUNCTION RELATED TO AGE, AND TO TREAT A CONDITION DISTRINGUED BY A DEFICIENCY OF THE FUNCTION OR NUMBER OF RECEIVERS CONNECTED TO MEMBRANE IN A FABRIC, ORGAN, CELL TYPE OR ORGANEL ". The invention describes the use of a quantity of saponins and sapogenins, mainly those with steroid structure, in the treatment of cognitive dysfunction and similar conditions. Treatment processes and pharmaceutical compositions are also described.